313 related articles for article (PubMed ID: 28339387)
1. Introduction to Quality Control in a Compounding Pharmacy.
Allen LV
Int J Pharm Compd; 2016; 20(6):481-484. PubMed ID: 28339387
[TBL] [Abstract][Full Text] [Related]
2. Analytic Methods Used in Quality Control in a Compounding Pharmacy.
Allen LV
Int J Pharm Compd; 2017; 21(1):31-37. PubMed ID: 28346196
[TBL] [Abstract][Full Text] [Related]
3. U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List).
Int J Pharm Compd; 2016; 20(6):457-458. PubMed ID: 28339383
[No Abstract] [Full Text] [Related]
4. The "Lists": What Do They Mean?
Voliva J
Int J Pharm Compd; 2016; 20(6):477-479. PubMed ID: 28339386
[No Abstract] [Full Text] [Related]
5. Quality planning, part 1: a holistic and practical approach.
Odegard RD
Int J Pharm Compd; 2013; 17(5):393-9. PubMed ID: 24459786
[TBL] [Abstract][Full Text] [Related]
6. Compounding pharmacies: before and after an inspection.
Kulkarni D; Ricketts S
Int J Pharm Compd; 2013; 17(5):358-62. PubMed ID: 24459779
[TBL] [Abstract][Full Text] [Related]
7. Quality Control: Photodocumentation in Pharmacy Compounding.
Allen LV
Int J Pharm Compd; 2022; 26(2):116-117. PubMed ID: 35413010
[TBL] [Abstract][Full Text] [Related]
8. Performance Improvement in 503A Compounding Pharmacies: A PLAN FOR ASSESSMENT, IMPLEMENTATION, AND SUSTAINED SUCCESS.
Pritchett J; Mixon W; O'Connell K
Int J Pharm Compd; 2016; 20(1):29-36. PubMed ID: 27125054
[TBL] [Abstract][Full Text] [Related]
9. 2013 State Compounding Legislation Tracker.
Miller DG
Int J Pharm Compd; 2013; 17(5):375-8. PubMed ID: 24459782
[No Abstract] [Full Text] [Related]
10. Quality Assurance and Quality Control, Part 2.
Akers MJ
Int J Pharm Compd; 2015; 19(3):215-21. PubMed ID: 26714362
[TBL] [Abstract][Full Text] [Related]
11. Regulatory framework of pharmaceutical compounding and actual developments of legislation in Europe.
Minghetti P; Pantano D; Gennari CG; Casiraghi A
Health Policy; 2014 Sep; 117(3):328-33. PubMed ID: 25110297
[TBL] [Abstract][Full Text] [Related]
12. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
Kastango ES
JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
[TBL] [Abstract][Full Text] [Related]
13. Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies.
Pritchett J; McCrory G; Kraemer C; Jensen B; Allen LV
Int J Pharm Compd; 2018; 22(1):7-16. PubMed ID: 29385381
[TBL] [Abstract][Full Text] [Related]
14. Drug product quality.
Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595
[No Abstract] [Full Text] [Related]
15. [Improving the quality of compounded medicines through self-assessment: proof of concept].
Wauters K; Fierens C; Corthout J; Sarre S; Saevels J
J Pharm Belg; 2014 Jun; (2):26-33. PubMed ID: 25055453
[TBL] [Abstract][Full Text] [Related]
16. Traditional vs. nontraditional pharmacy.
Allen LV
Int J Pharm Compd; 2013; 17(4):351. PubMed ID: 24261152
[No Abstract] [Full Text] [Related]
17. Unlicensed pharmaceutical preparations for clinical patient care: Ensuring safety.
de Wilde S; de Jong MGH; Le Brun PPH; Guchelaar HJ; Schimmel KJM
Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):3-8. PubMed ID: 29047193
[TBL] [Abstract][Full Text] [Related]
18. Compounding pharmacies: who is in charge?
Pergolizzi JV; Labhsetwar S; LeQuang JA
Pain Pract; 2013 Mar; 13(3):253-7. PubMed ID: 23350709
[TBL] [Abstract][Full Text] [Related]
19. FDA, states discuss pharmacy compounding regulatory framework.
Traynor K
Am J Health Syst Pharm; 2013 Feb; 70(3):180, 182. PubMed ID: 23327976
[No Abstract] [Full Text] [Related]
20. U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies.
Yoch D
Int J Pharm Compd; 2017; 21(2):95-102. PubMed ID: 28346203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
